全文获取类型
收费全文 | 70474篇 |
免费 | 6180篇 |
国内免费 | 3110篇 |
专业分类
耳鼻咽喉 | 754篇 |
儿科学 | 1633篇 |
妇产科学 | 1276篇 |
基础医学 | 8687篇 |
口腔科学 | 1328篇 |
临床医学 | 6346篇 |
内科学 | 7167篇 |
皮肤病学 | 907篇 |
神经病学 | 2722篇 |
特种医学 | 3581篇 |
外国民族医学 | 55篇 |
外科学 | 8153篇 |
综合类 | 11788篇 |
现状与发展 | 24篇 |
预防医学 | 2057篇 |
眼科学 | 684篇 |
药学 | 4868篇 |
46篇 | |
中国医学 | 2050篇 |
肿瘤学 | 15638篇 |
出版年
2024年 | 166篇 |
2023年 | 992篇 |
2022年 | 2252篇 |
2021年 | 3005篇 |
2020年 | 2407篇 |
2019年 | 2163篇 |
2018年 | 1973篇 |
2017年 | 2271篇 |
2016年 | 2579篇 |
2015年 | 2797篇 |
2014年 | 4225篇 |
2013年 | 4378篇 |
2012年 | 3866篇 |
2011年 | 4321篇 |
2010年 | 3488篇 |
2009年 | 3561篇 |
2008年 | 3564篇 |
2007年 | 3825篇 |
2006年 | 3470篇 |
2005年 | 3079篇 |
2004年 | 2691篇 |
2003年 | 2312篇 |
2002年 | 2137篇 |
2001年 | 1935篇 |
2000年 | 1594篇 |
1999年 | 1441篇 |
1998年 | 1231篇 |
1997年 | 1151篇 |
1996年 | 984篇 |
1995年 | 904篇 |
1994年 | 761篇 |
1993年 | 611篇 |
1992年 | 487篇 |
1991年 | 408篇 |
1990年 | 319篇 |
1989年 | 306篇 |
1988年 | 300篇 |
1987年 | 248篇 |
1986年 | 201篇 |
1985年 | 252篇 |
1984年 | 236篇 |
1983年 | 139篇 |
1982年 | 187篇 |
1981年 | 154篇 |
1980年 | 97篇 |
1979年 | 96篇 |
1978年 | 69篇 |
1977年 | 46篇 |
1976年 | 43篇 |
1975年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
131.
We report a case of extragastrointestinal stromal tumor possibly originating from the prostate. The patient underwent radical prostatectomy because of no metastatic evidence. No recurrence and metastasis have been found during 14 months of follow up. To our knowledge, this may be the third such case published in a report in terms of pathological type. 相似文献
132.
Clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cava 总被引:1,自引:0,他引:1
Tomoaki Terakawa Hideaki Miyake Atsushi Takenaka Isao Hara Masato Fujisawa 《International journal of urology》2007,14(9):781-784
BACKGROUND: The objective of this study was to evaluate the clinical outcome after surgical management of renal cell carcinoma (RCC) extending to the inferior vena cava (IVC). METHODS: This study included a total of 55 patients (41 men and 14 women; mean age, 59.3 years) with RCC (39 right- and 16 left-sided tumors) involving the IVC, who underwent radical nephrectomy and tumor thrombectomy between 1983 and 2005 at a single institution in Japan. The level of thrombus was classified as follows: level I, infrahepatic; level II, intrahepatic; level III, suprahepatic; and level IV, extending to the atrium. Clinicopathological data from these patients were retrospectively reviewed to identify factors associated with survival. RESULTS: There were 11 and 18 patients who were diagnosed as having lymph node and distant metastases, respectively. Twenty-two patients had tumor thrombus in level I, 20 in level II, 10 in level III, and 3 in level IV. Pathological examinations demonstrated that 34 and 21 patients had clear cell carcinoma and non-clear cell carcinoma, respectively, 42, 9 and 4 were pT3b, pT3c and pT4, respectively, and 6, 35 and 14 were Grades 1, 2 and 3, respectively. Cancer-specific 1-, 3- and 5-year survival rates of these 55 patients were 74.5%, 51.4% and 30.3%, respectively. Among several factors examined, clinical stage (P = 0.047), lymph node metastasis (P = 0.016), histological subtype (P = 0.034) and tumor grade (P < 0.001) were significantly associated with cancer-specific survival by univariate analysis. Furthermore, multivariate analysis demonstrated clinical stage (P = 0.037) and tumor grade (P < 0.001) as independent predictors of cancer-specific survival irrespective of other significant factors identified by univariate analysis. CONCLUSIONS: In patients with RCC involving the IVC, biological aggressiveness characterized by tumor grade rather than tumor extension would have more potential prognostic importance; therefore, more intensive multimodal therapy should be considered in patients with high grade RCC with tumor thrombus extending into the IVC. 相似文献
133.
Testicular cancer with tumor thrombus extending to the inferior vena cava successfully removed using veno-venous bypass: A case report 总被引:1,自引:0,他引:1
Yoshiaki Kinebuchi Teruyuki Ogawa Haruaki Kato Yasuhiko Igawa Osamu Nishizawa Shin-Ichi Miyagawa 《International journal of urology》2007,14(5):458-460
A 33-year-old man with a left testicular tumor was referred to Shinshu University Hospital for advanced therapy. Radiographic imaging revealed multiple metastases in the retroperitoneal lymph nodes (RPLN) and bilateral lungs, as well as tumor thrombus that extended from the left renal vein to the inferior vena cava (IVC) adjacent to the right atrium. After orchidectomy, a diagnosis of embryonal carcinoma was made with a clinical stage of T1N2M1bS3, which has a poor prognosis, based on the International Germ Cell Cancer Collaborative Group consensus. After eight courses of chemotherapy, the patient's tumor markers normalized and the lung metastases disappeared, but the RPLN and tumor thrombus remained. Retroperitoneal lymph node dissection and thrombectomy were performed using a veno-venous bypass (VVB). The pathological examination of the thrombus revealed a mature teratoma. The patient has been disease-free since surgery. 相似文献
134.
Masafumi Kumano Hideaki Miyake Isao Hara Junya Furukawa Atsushi Takenaka Masato Fujisawa 《International journal of urology》2007,14(4):336-338
BACKGROUND: The objective of this study was to evaluate the efficacy and safety of first-line high-dose chemotherapy (HDCT) combined with peripheral blood stem cell transplantation (PBSCT) for patients with advanced extragonadal germ cell tumors (EGGCT). METHODS: Six male patients with advanced non-seminomatous EGGCT were treated with HDCT combined with PBSCT following 2-3 cycles of conventional-dose induction chemotherapy. The regimens used for HDCT were carboplatin, etoposide and ifosfamide (ICE) in five patients and ICE plus paclitaxel (T-ICE) in one patient, and that for induction therapy was cisplatin, etoposide and bleomycin (PEB) in all patients. As a rule, HDCT was continuously administered until alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin normalized (beta-HCG). RESULTS: Following 1-6 courses of HDCT (median, 4 courses), beta-HCG and AFP were normalized in all patients, and five and one patient were diagnosed as showing partial remission and stable disease, respectively. Five patients underwent surgical resection of residual tumors after HDCT, yielding necrotic tissue in two, mature teratoma in two, and viable cancer tissue in one, and the surgical margin was negative in all patients. At a median follow-up of 36 months, five patients were alive and disease-free, whereas the remaining one died of disease progression. Although all patients had grade 3 hematological toxicity, there was no treatment-related death by combining PBSCT. CONCLUSIONS: First-line HDCT with PBSCT could be safely administered to patients with advanced EGGCT, and the antitumor effect of this treatment was comparatively favorable. First-line HDCT therefore may represent an attractive option for patients with advanced EGGCT. 相似文献
135.
Tsuneharu Miki Yoichi Mizutani Hideyuki Akaza Seiichiro Ozono Taiji Tsukamoto Toshiro Terachi Katsusuke Naito Norio Nonomura Isao Hara Osamu Yoshida The Japan Blood Cell Transplantation Study Group for Testicular Germ Cell Tumor 《International journal of urology》2007,14(1):54-59
OBJECTIVE: Standard chemotherapy shows relatively low long-term survival in patients with poor-risk testicular germ cell tumor (GCT). First-line high-dose chemotherapy (HD-CT) may improve the result. High-dose carboplatin, etoposide, ifosfamide chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT) was investigated as first-line chemotherapy in patients with advanced testicular GCT. METHODS: Fifty-five previously untreated testicular GCT patients with Indiana 'advanced disease' criteria received three cycles of bleomycin, etoposide and cisplatin (BEP) followed by one cycle of HD-CT plus PBSCT, if elevated serum tumor markers were observed after three cycles of the BEP regimen. RESULTS: Thirty patients were treated with BEP alone, because the tumor marker(s) declined to normal range. Twenty-five patients received BEP and HD-CT. One patient died of rhabdomyolysis due to HD-CT. Three and six (13% and 25%) out of 24 patients treated with BEP and HD-CT achieved marker-negative and marker-positive partial responses, respectively. The other patients achieved no change. Fifteen (63%) are alive and 14 (58%) are free of disease at a median follow-up time of 54 months. Severe toxicity included treatment-related death (4%). CONCLUSIONS: HD-CT with peripheral stem cell support can be successfully applied in a multicenter setting. HD-CT demonstrated modest anticancer activity for Japanese patients with advanced testicular GCT and was well tolerated. This regimen might be examined for further investigation in randomized trials in first-line chemotherapy for patients with poor-risk testicular GCT. 相似文献
136.
Solitary fibrous tumors (SFT) have recently been established to be of mesenchymal origin. Although there are numerous reports
of SFTs arising from the pleura, reports of the tumor arising from extrapleural sites are comparatively rare [Fletcher CDM,
Unni K, Mertens F (eds) World Health Organization classification of tumors, pathology & genetics, tumors of soft tissue and bone. IARC Press, Lyon, pp 86–901, 2002]. We report a case of SFT arising in the inguinal region. 相似文献
137.
子宫内膜异位症患者血清TNF-α和TNF-β的测定 总被引:7,自引:1,他引:6
目的:了解子宫内膜异位症(简称内异症)患者血清中肿瘤坏死因子-α(TNF-α)和肿瘤坏死因子-β(TNF-β)的水平以及在腹腔镜保守性手术治疗前后的变化。方法:采用酶联免疫吸附法检测82例内异症患者(内异症组)和68例非内异症妇女(对照组)血清中TNF-α和TNF-β的含量及49例手术前后两者水平的变化。结果:内异症组血清TNF-α和TNF-β含量均显著高于对照组(P<0.01),且二者表达量随病情加重有上升趋势(P<0.05)。手术后Ⅲ~Ⅳ期患者血清中的TNF-α和Ⅰ~Ⅳ期患者血清TNF-β的含量随着内异灶的清除逐渐下降。结论:检测患者血清中TNF-α和TNF-β的含量,对术后随访、监测及手术效果的评价具有重要意义。 相似文献
138.
目的 探讨发作性睡病与HLA—DQB1基因的相关性。方法 对30例发作性睡病患者的临床资料进行分析。用序列特异性引物-聚合酶链反应(PCR-SSP)分型技术测定HLA—DQB1等位基因,并与44例健康人检测的数据进行比较。结果 发作性睡病患者组DQB1*0602基因频率为40%,与正常对照组9.09%相比较明显增高;未检出DQB1*0401—0402基因,与正常对照组9.09%相比较,经统计学分析,差异有显著性(P〈0.05)。结论 HLA—DQB1*0602基因为中国发作性睡病人群的易感基因;HLA-DQB1*0401—0402基因为中国发作性睡病人群的保护基因。 相似文献
139.
Radiofrequency-ablation of unresectable primary and secondary liver tumors: results in 88 patients 总被引:5,自引:0,他引:5
Philipp Hildebrand Markus Kleemann Uwe J. Roblick Lutz Mirow Matthias Birth Thorsten Leibecke Hans-Peter Bruch 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2006,391(2):118-123
Background and aims Radiofrequency-ablation (RFA) is increasingly used for destruction of unresectable primary and secondary liver tumors. We
report our experience in the use of RFA for the management of unresectable hepatic malignancies.
Patients and methods Between February 2000 and December 2004 we have undertaken 120 RFA procedures to ablate 426 unresectable primary or metastatic
liver tumors in 88 patients. RFA was performed via laparotomy (n=68), laparoscopy (n=9) or a percutaneous approach (n=43). Primary liver cancer was treated in seven patients (8%) and metastatic liver tumors were treated in 81 patients (92%).
All patients were followed to assess complications, treatment response and recurrence of malignant disease.
Results Procedure-related complication rate was low (3.4%). During a mean follow-up of 21.2 months, 15 patients had local tumor progression
(17%), 21 patients (23,9%) had new malignant disease and 27 patients (30.7%) died from intervention-unrelated complications
of their malignant disease. Additional liver lesions were identified in 27 (35%) of 77 cases by intraoperative ultrasound.
Thirty-six patients received simultaneous resection and RFA.
Conclusion RFA is a safe, well-tolerated and effective treatment for patients with unresectable primary and secondary liver malignancies. 相似文献
140.
目的探讨MR检查在颈静脉球瘤诊断中的应用价值。方法对15例病变进行回顾性分析,重点分析其部位、信号及其侵袭性表现等情况。结果15例患者中,右侧病变8个(8/15),左侧7个(7/15);肿瘤形态为类圆形或不规则形,12例较大病变不同程度侵犯颈静脉孔区、乳突、岩骨、岩尖、斜坡等处骨质;肿瘤信号欠均匀,12个(12/15)肿块在MR平扫出现“盐和胡椒征”,以“胡椒”表现最为显著;13个肿块(13/13)均有明显强化,其中10个肿块出现“盐和胡椒征”。9例行MRA检查,颈内动脉和颈内静脉不同程度移位和包绕。结论根据肿瘤的部位、“盐和胡椒征”等MR表现,可在手术前正确诊断颈静脉球瘤。 相似文献